Welcome to the Oncomine Blog

University of Munich Evaluates the Oncomine Comprehensive Plus Assay for HRD Detection

09/22/2021

Our OncomineWorld event in 2021 brought thousands of professionals together from around the world to advance our understanding of next-generation sequencing (NGS) in precision oncology research. By enabling simultaneous, comprehensive genomic..

Breakthrough Device Designation for Oncomine Dx ...

Philip Scard knew immediately and intimately that the June 15 news release from Thermo Fisher ...

The Impact of NGS in Hematology-Oncology

In aggressive forms of cancer such as acute myeloid leukemia (AML), accurate diagnosis is needed as ...

The OncomineWorld Experience from Behind the ...

BACKGROUND:  There is little to no point in saying that we are all living in an unprecedented time, ...

Comprehensive Biomarker Testing Reveals RET ...

It’s been a tough road for Melissa Crouse, sometimes almost deadly. She had a lobe of her left lung ...

Building a Case for In-House Next Generation ...

Diagnostics lab team demonstrates how insourcing NGS makes sound financial sense and helps deliver ...

Q2 Solutions Eyes Genexus System as its ...

When it comes to supporting clinical trials, having a global footprint is simply not enough for ...

Shifting the Paradigm: Broader Patient Access to ...

We are living in an unprecedented time in the collective fight against cancer, where recent ...

The Importance of Detecting the Most Fusions ...

In recent years, we’ve seen an increasing number of new therapies emerge that target gene fusions ...